
Beth Karlan
Director, Cancer Population Genetics - UCLA Hematology and Oncology, Beverly Hills · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · · ·
History
PresentDepartment of Obstetrics and Gynecology · UCLA David Geffen School of Medicine/UCLA Medical Center
PresentWomen's Health Research in UCLA Obstetrics and Gynecology · UCLA David Geffen School of Medicine/UCLA Medical Center
PresentCancer Population Genetics at the UCLA Health Jonsson Comprehensive Cancer Center · UCLA David Geffen School of Medicine/UCLA Medical Center

1986–1987

- 1978–1982
- 1974–1978
Harvard-Radcliffe College
Research
Review · Nature Reviews Disease Primers · 2016 · Last of 6 authors · 1,066 citations
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Nature reviews. Cancer · 2015 · 971 citations
Journal of the National Comprehensive Cancer Network · 2021 · 914 citations

86 papers

77 papers · 8 as a resident
- KO
60 papers

60 papers

60 papers
- TP
56 papers

55 papers
- DL
53 papers
Grants
- 2020–2031
Patient Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)
National Cancer Institute · T32
PI · $457.9K · University of California Los Angeles
- 2009–2017
Pacific Ovarian Cancer Research Consortium
National Cancer Institute · P50
Project lead · $694.4K · Fred Hutchinson Cancer Research Center
- 1997–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $168.7K · Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
National Center for Research Resources · S07
Project lead · Cedars-Sinai Medical Center
Clinical trials
- 2009–2015
A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Principal investigator · Completed
Fred Hutchinson Cancer Center
- 2020–2047
Site PI · Recruiting
NRG Oncology



